OBJECTIVE: Does psychosocial intervention for caregivers whose spouses with Alzheimer disease (AD) are taking donepezil delay nursing home (NH) placement or death of patients? DESIGN: Randomized controlled trial with 2 years of active treatment and up to 8.5 years of follow-up (mean: 5.4 years, SD: 2.4). SETTING: Outpatients of research clinics in Australia, the United Kingdom, and the United States. PARTICIPANTS: One hundred and fifty-five persons with AD and their spouses. INTERVENTION: Five sessions of individual and family counseling (+ prn ad hoc counseling) or usual care. MEASUREMENTS: Time to institutionalization and death using Cox proportional hazards methods. RESULTS: Over a mean of 5.4 years (SD: 2.4), there were no differences in NH placement or mortality by intervention group, but there were by country, with Australian patients admitted to NHs earlier than U.S. than U.K. patients. CONCLUSION: Earlier NH admission of Australian compared to U.K. and U.S. subjects may be due to differences in health care, NH systems, availability, and affordability.
RCT Entities:
OBJECTIVE: Does psychosocial intervention for caregivers whose spouses with Alzheimer disease (AD) are taking donepezil delay nursing home (NH) placement or death of patients? DESIGN: Randomized controlled trial with 2 years of active treatment and up to 8.5 years of follow-up (mean: 5.4 years, SD: 2.4). SETTING: Outpatients of research clinics in Australia, the United Kingdom, and the United States. PARTICIPANTS: One hundred and fifty-five persons with AD and their spouses. INTERVENTION: Five sessions of individual and family counseling (+ prnad hoc counseling) or usual care. MEASUREMENTS: Time to institutionalization and death using Cox proportional hazards methods. RESULTS: Over a mean of 5.4 years (SD: 2.4), there were no differences in NH placement or mortality by intervention group, but there were by country, with Australian patients admitted to NHs earlier than U.S. than U.K. patients. CONCLUSION: Earlier NH admission of Australian compared to U.K. and U.S. subjects may be due to differences in health care, NH systems, availability, and affordability.
Authors: Howard Feldman; Serge Gauthier; Jane Hecker; Bruno Vellas; Birol Emir; Vera Mastey; Ponni Subbiah Journal: J Am Geriatr Soc Date: 2003-06 Impact factor: 5.562
Authors: Eric B Larson; Marie-Florence Shadlen; Li Wang; Wayne C McCormick; James D Bowen; Linda Teri; Walter A Kukull Journal: Ann Intern Med Date: 2004-04-06 Impact factor: 25.391
Authors: Quincy M Samus; Deirdre Johnston; Betty S Black; Edward Hess; Christopher Lyman; Amrita Vavilikolanu; Jane Pollutra; Jeannie-Marie Leoutsakos; Laura N Gitlin; Peter V Rabins; Constantine G Lyketsos Journal: Am J Geriatr Psychiatry Date: 2014-01-04 Impact factor: 4.105
Authors: Margaret L Longacre; John A Ridge; Barbara A Burtness; Thomas J Galloway; Carolyn Y Fang Journal: Oral Oncol Date: 2011-12-09 Impact factor: 5.337
Authors: D Eldon Spackman; Srikanth Kadiyala; Peter J Neumann; David L Veenstra; Sean D Sullivan Journal: Curr Alzheimer Res Date: 2012-11 Impact factor: 3.498
Authors: Christopher M Callahan; Greg Arling; Wanzhu Tu; Marc B Rosenman; Steven R Counsell; Timothy E Stump; Hugh C Hendrie Journal: J Am Geriatr Soc Date: 2012-05 Impact factor: 5.562
Authors: Wei Duan-Porter; Kristen Ullman; Christina Rosebush; Lauren McKenzie; Kristine E Ensrud; Edward Ratner; Nancy Greer; Tetyana Shippee; Joseph E Gaugler; Timothy J Wilt Journal: J Gen Intern Med Date: 2020-01-02 Impact factor: 5.128